ZENOVO HS LIMITEDActive

Company number 10770488Private limited companyIncorporated 2017

Key figures

£44-95.5%
Net assets 2025/26
-62.0%
Average annual change 2019/20–2025/26
05 k10 k15 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, ZENOVO HS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k30 k2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Total assets26,45621,21823,42418,20912,594
Total liabilities10,96511,19017,97216,45611,770
Net assets / total equity14,5919,2484,67297344
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principal activity of the company during the year under review was medical services.

As described in the company's latest filed accounts.

Summary: ZENOVO HS LIMITED

Company

ZENOVO HS LIMITED is a private limited company registered with Companies House under company number 10770488. It was incorporated on 15 May 2017. Its status is active. The registered office is in Bracknell (RG12). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 May 2026); the company files micro-entity accounts. Net assets were £44, down 95.5% on the previous year. Total assets were £12,594 and total liabilities £11,770. The company had an average of 1 employee. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 29 Feb 2028. The next confirmation statement is due by 28 May 2027.